Given that genetic and environmental factors are associated with circulating IGF levels, the hypothesis that IGF-1 and IGFBP-3 polymorphisms, BMI, and dietary intake of soy isoflavone may work together in affecting BC risk warrants further investigation. Here, IGF1 is linked to breast cancer.